نتایج جستجو برای: fibroblastic growth factor receptor 1 fgfr1

تعداد نتایج: 4125718  

2014
Yaozong Zhang Nan Su Fengtao Luo Xuan Wen Yubin Tang Jing Yang Siyu Chen Wanling Jiang Xiaolan Du Lin Chen

Endothelial progenitor cells (EPCs) contribute to neovascularization and vascular repair, and may exert a beneficial effect on the clinical outcome of sepsis. Osteoblasts act as a component of "niche" in bone marrow, which provides a nest for stem/progenitor cells and are involved in the formation and maintenance of stem/progenitor cells. Fibroblast growth factor receptor 1 (FGFR1) can regulate...

2017
Xu-Hua Qiu Feng Li Hong-Qin Cao Jing-Jing Shao Jian-Gang Mei Han-Qing Li Yong-Ping Zhai

8p11 myeloproliferative syndrome (EMS) is a rare disease characterized by the constitutive activation of fibroblast growth factor receptor 1 (FGFR1). To date, four cases of EMS with the chromosomal translocation, t(1;8)(q25;p11.2), have been reported. In the present study, TPR‑FGFR1‑expressing Baf3 cells were established and confirmed by polymerase chain reaction. To identify the most promising...

Journal: :American journal of human genetics 2005
Kenneth E White Jose M Cabral Siobhan I Davis Tonya Fishburn Wayne E Evans Shoji Ichikawa Joanna Fields Xijie Yu Nick J Shaw Neil J McLellan Carole McKeown David Fitzpatrick Kai Yu David M Ornitz Michael J Econs

Activating mutations in the genes for fibroblast growth factor receptors 1-3 (FGFR1-3) are responsible for a diverse group of skeletal disorders. In general, mutations in FGFR1 and FGFR2 cause the majority of syndromes involving craniosynostosis, whereas the dwarfing syndromes are largely associated with FGFR3 mutations. Osteoglophonic dysplasia (OD) is a "crossover" disorder that has skeletal ...

Journal: :Journal of Thoracic Oncology 2009

2015
Liping Zhang Hui Yu Andrzej Badzio Theresa A. Boyle Hans-Ulrich Schildhaus Xian Lu Rafal Dziadziuszko Jacek Jassem Marileila Varella-Garcia Lynn E. Heasley Ashley A. Kowalewski Kim Ellison Gang Chen Caicun Zhou Fred R. Hirsch

INTRODUCTION Small-cell lung cancer (SCLC) accounts for 15% of all lung cancers and has been understudied for novel therapies. Signaling through fibroblast growth factors (FGF2, FGF9) and their high-affinity receptor has recently emerged as a contributing factor in the pathogenesis and progression of non-small-cell lung cancer. In this study, we evaluated fibroblast growth factor receptor 1 (FG...

Journal: :Development 1997
B G Ciruna L Schwartz K Harpal T P Yamaguchi J Rossant

Fibroblast growth factor (FGF) signaling has been implicated in the patterning of mesoderm and neural lineages during early vertebrate development. In the mouse, FGF receptor-1 (FGFR1) is expressed in an appropriate spatial and temporal manner to be orchestrating these functions. Mouse embryos homozygous for a mutated Fgfr1 allele (fgfr1(delta tmk)) die early in development, show abnormal growt...

2014
Osamu Tohyama Junji Matsui Kotaro Kodama Naoko Hata-Sugi Takayuki Kimura Kiyoshi Okamoto Yukinori Minoshima Masao Iwata Yasuhiro Funahashi

Inhibition of tumor angiogenesis by blockading the vascular endothelial growth factor (VEGF) signaling pathway is a promising therapeutic strategy for thyroid cancer. Lenvatinib mesilate (lenvatinib) is a potent inhibitor of VEGF receptors (VEGFR1-3) and other prooncogenic and prooncogenic receptor tyrosine kinases, including fibroblast growth factor receptors (FGFR1-4), platelet derived growth...

Journal: :The Journal of endocrinology 2000
T J Peters B M Chapman M W Wolfe M J Soares

Trophoblast giant cells are one of the primary endocrine cell types of the rodent placenta. Placental lactogen-I (PL-I) is the initial prolactin (PRL) family member expressed as trophoblast giant cells differentiate. In this report, we use the Rcho-1 trophoblast cell line as a model for studying the regulation of PL-I gene expression during trophoblast giant cell differentiation. Evidence is pr...

Journal: :Development 2005
Cuiling Li Xiaoling Xu Danielle K Nelson Trevor Williams Michael R Kuehn Chu-Xia Deng

Fibroblast growth factors (FGFs) and their receptors have been implicated in limb development. However, because of early post-implantation lethality associated with fibroblast growth factor receptor 1 (FGFR1) deficiency, the role of this receptor in limb development remains elusive. To overcome embryonic lethality, we have performed a conditional knockout of Fgfr1 using the Cre-LoxP approach. W...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید